MA32800B1 - Solution a base d'uree format un film pour le traitement du psoriasis des ongles - Google Patents

Solution a base d'uree format un film pour le traitement du psoriasis des ongles

Info

Publication number
MA32800B1
MA32800B1 MA33852A MA33852A MA32800B1 MA 32800 B1 MA32800 B1 MA 32800B1 MA 33852 A MA33852 A MA 33852A MA 33852 A MA33852 A MA 33852A MA 32800 B1 MA32800 B1 MA 32800B1
Authority
MA
Morocco
Prior art keywords
film
urea
treatment
based solution
nail psoriasis
Prior art date
Application number
MA33852A
Other languages
Arabic (ar)
English (en)
Inventor
Sophie Chesnoy
Marlène DELAUNOIS
Héla Coubetergues
Pascal Lefrancois
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of MA32800B1 publication Critical patent/MA32800B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

L'invention concerne une solution formant un film renfermant : 10 à 20 % d'urée, 5 à 15 % de polymère formant un film, 45 à 65 % d'un solvant polaire, 1 à 20 % d'un cosolvant, 0,01 à 5 % d'un agent plastifiant choisi dans la liste constituée de phtalate de diéthyle, citrate de triéthyle, sébacate de dibutyle, sébacate de diéthyle, phtalate de dibutyle, citrate d'acétyltriéthyle et de polyéthylène glycols, et d'eau pour compléter à 100 %, prévue pour le traitement des infections fongiques unguéales et du psoriasis des ongles.
MA33852A 2008-10-21 2011-05-17 Solution a base d'uree format un film pour le traitement du psoriasis des ongles MA32800B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857146A FR2937250B1 (fr) 2008-10-21 2008-10-21 Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
PCT/EP2009/063771 WO2010046375A1 (fr) 2008-10-21 2009-10-21 Solution à base d’urée formant un film pour le traitement du psoriasis des ongles

Publications (1)

Publication Number Publication Date
MA32800B1 true MA32800B1 (fr) 2011-11-01

Family

ID=40823172

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33852A MA32800B1 (fr) 2008-10-21 2011-05-17 Solution a base d'uree format un film pour le traitement du psoriasis des ongles

Country Status (23)

Country Link
US (1) US20110200544A1 (fr)
EP (1) EP2349243B1 (fr)
JP (1) JP2012506372A (fr)
KR (1) KR20110071118A (fr)
CN (1) CN102186468B (fr)
AR (1) AR074048A1 (fr)
AU (1) AU2009306462B2 (fr)
BR (1) BRPI0919833A2 (fr)
CA (1) CA2740001A1 (fr)
ES (1) ES2560178T3 (fr)
FR (1) FR2937250B1 (fr)
GE (1) GEP20135746B (fr)
IL (1) IL212372A0 (fr)
MA (1) MA32800B1 (fr)
MX (1) MX2011004016A (fr)
NZ (1) NZ592733A (fr)
PL (1) PL2349243T3 (fr)
PT (1) PT2349243E (fr)
RU (1) RU2508090C2 (fr)
TN (1) TN2011000167A1 (fr)
UA (1) UA102705C2 (fr)
WO (1) WO2010046375A1 (fr)
ZA (1) ZA201103437B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5840437B2 (ja) * 2011-09-30 2016-01-06 日本メナード化粧品株式会社 抗炎症剤
US20140271529A1 (en) * 2013-03-14 2014-09-18 Alc Therapeutics, Llc Antifungal compositions for the treatment of secondary skin and nail infections
CN104758273B (zh) * 2015-04-09 2018-04-20 山东罗欣药业集团股份有限公司 一种尿素微囊制剂及其制备方法
US20220249859A1 (en) * 2021-02-09 2022-08-11 Scholl's Wellness Company Llc Formulation and device for cosmetic treatment of onychomycosis
WO2026046372A1 (fr) * 2024-08-30 2026-03-05 Shenzhen Pharmacin Co., Ltd. Compositions pour problèmes d'ongles et leurs utilisations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613227B1 (fr) * 1987-04-01 1990-12-28 Oreal Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
ATE320250T1 (de) * 2000-01-03 2006-04-15 Karl Kraemer Zubereitungen zur atraumatischen nagelentfernung
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
BR0206307A (pt) * 2001-01-09 2004-07-20 Israel Dvoretzky Composição terapêutica formadora de pelìcula e sistema de tratamento para a mesma
DE10126501A1 (de) * 2001-05-30 2002-12-12 Aventis Pharma Gmbh Zubereitung zur Entfernung von abnormen Keratinmaterial
US6821508B2 (en) * 2001-06-27 2004-11-23 Rutgers, The State University Composition and method for topical nail treatment
ATE499929T1 (de) * 2001-09-04 2011-03-15 Trommsdorff Arzneimittel Verwendung eines pflasters zur behandlung von nagelpilzerkrankungen
US20040071760A1 (en) * 2002-01-07 2004-04-15 Israel Dvoretzky Therapeutic film forming composition and treatment system therefor
MXPA05002065A (es) * 2002-09-05 2005-06-08 Galderma Sa Solucion para aplicacion ungueal.
CN1215838C (zh) * 2003-06-25 2005-08-24 蚌埠丰原医药科技发展有限公司 双氯芬酸钠贴剂及其制备方法
CA2533720A1 (fr) * 2003-07-29 2005-02-10 Pierre Fabre Dermo-Cosmetique Vernis a ongles a action antimycosique
DE10341944A1 (de) * 2003-09-11 2005-04-28 York Pharma Plc Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff

Also Published As

Publication number Publication date
FR2937250B1 (fr) 2013-05-10
RU2508090C2 (ru) 2014-02-27
AU2009306462A1 (en) 2010-04-29
PL2349243T3 (pl) 2016-07-29
US20110200544A1 (en) 2011-08-18
EP2349243B1 (fr) 2015-11-11
AR074048A1 (es) 2010-12-22
PT2349243E (pt) 2016-03-14
CN102186468B (zh) 2014-02-12
AU2009306462B2 (en) 2013-08-22
ZA201103437B (en) 2012-01-25
MX2011004016A (es) 2011-05-19
BRPI0919833A2 (pt) 2015-12-15
RU2011119924A (ru) 2012-11-27
JP2012506372A (ja) 2012-03-15
IL212372A0 (en) 2011-06-30
KR20110071118A (ko) 2011-06-28
NZ592733A (en) 2012-03-30
GEP20135746B (en) 2013-02-11
FR2937250A1 (fr) 2010-04-23
ES2560178T3 (es) 2016-02-17
CN102186468A (zh) 2011-09-14
HK1156532A1 (en) 2012-06-15
WO2010046375A1 (fr) 2010-04-29
CA2740001A1 (fr) 2010-04-29
UA102705C2 (ru) 2013-08-12
TN2011000167A1 (en) 2012-12-17
EP2349243A1 (fr) 2011-08-03

Similar Documents

Publication Publication Date Title
MA32800B1 (fr) Solution a base d&#39;uree format un film pour le traitement du psoriasis des ongles
ATE440117T1 (de) Polymermicellen für die arzneistoffzufuhr
EP3390443A4 (fr) Anticorps anti-myostatine, polypeptides contenant des variants de régions fc, et procédés d&#39;utilisation
EP3240804A4 (fr) Anticorps anti-myostatine, polypeptides contenant des variants de régions fc, et procédés d&#39;utilisation
EP3328541A4 (fr) Catalyseur d&#39;oxydation de diesel
EP3277698A4 (fr) Composition filmogène contenant du si et ses procédés d&#39;utilisation
EP2560653A4 (fr) Certaines amino-pyridazines, compositions contenant ces dernières et leurs procédés d&#39;utilisation
MX2017013535A (es) Metodos y composiciones de limpieza personal concentradas.
EP2751135A4 (fr) Agents de capture spécifiques du vegf, compositions en contenant et leurs procédés d&#39;utilisation et de production
EP3472200A4 (fr) Anticorps anti-myostatine et leurs procédés d&#39;utilisation
EP2476070A4 (fr) Procédé et appareil pour le partage sélectif d&#39;ensembles d&#39;informations sémantiques
EP2629799A4 (fr) Base topique et compositions contenant un principe actif, et procédés d&#39;amélioration et de traitement de la peau
DK3793534T3 (da) Oral tablet til levering af aktive ingredienser til mavetarmkanalen
TN2014000195A1 (fr) 2-thiopyrimidinones
EP2761898A4 (fr) Attribution dynamique d&#39;identificateurs de message de diffusion cellulaire
EP3322526A4 (fr) Catalyseurs multimétalliques contenant du cuivre améliorés et procédé d&#39;utilisation de ceux-ci pour produire du 1,2-propane-diol d&#39;origine biologique
CY1118173T1 (el) 5-[(3,3,3-τριφθορο-2-υδροξυ-1-αρυλπροπυλ)αμινο]-1h-κινολιν-2-ονες, μια διεργασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδων παραγοντων
DK2306988T3 (da) Farmaceutisk formulering til behandling af den øvre fordøjelseskanal
EP3579888A4 (fr) Compositions génératrices de gazotransmetteurs électrochimiques et leurs procédés d&#39;utilisation et pansements et systèmes de traitement incorporant celles-ci
EP2601951A4 (fr) Composition pharmaceutique destinée au traitement d&#39;une hémorragie provoquée par un trouble de la coagulation et utilisation associée
EP3833366A4 (fr) Mélanges de micro-organismes, molécules dérivées de ceux-ci et leurs procédés d&#39;utilisation
MX371306B (es) Composiciones concentradas para la limpieza personal y usos.
EA201590475A1 (ru) Тетрациклиновые соединения
EP2904381A4 (fr) Points de polymère semi-conducteur contenant du métal et leurs procédés de fabrication et d&#39;utilisation
BR112019023830A2 (pt) processo para preparar metacroleína